{"id":"W4387826635","doi":"10.1016/j.annonc.2023.09.1143","title":"1914MO The clinico-radiological outcome of desmoid type-fibromatosis after discontinuing the sorafenib treatment in responders: Single-arm phase II clinical trial","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Chugai Pharmaceutical; Ipsen; PharmaMar; Les Laboratories Pierre Fabre; AstraZeneca","keywords":"Medicine; Sorafenib; Radiological weapon; Fibromatosis; Aggressive fibromatosis; Oncology; Clinical trial; Internal medicine; Radiology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001246107,0.0006524897,0.001357672,0.0003064139,0.0004071853,0.0007950455,0.0003406181,0.001243147,0.004725096],"category_scores_gemma":[0.0008499742,0.0002590034,0.001254525,0.000222734,0.0005389384,0.0005905863,0.0002173931,0.001820771,0.0009453348],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004317729,"about_ca_system_score_gemma":0.0004465522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004512762,"about_ca_topic_score_gemma":0.0009347287,"domain_scores_codex":[0.9996319,0.0001549427,0.00002206261,0.00005521575,0.00003638327,0.00009958987],"domain_scores_gemma":[0.9994431,0.000125987,0.000115175,0.00005351627,0.00004156,0.0002205919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8142766,0.0338128,0.01615713,0.0008308999,0.001808345,0.0005506846,0.0001837967,0.001438265,0.01643692,0.0002715917,0.004025093,0.1102079],"study_design_scores_gemma":[0.3631626,0.5851325,0.03975524,0.0001131656,0.00115594,0.0006281689,0.0001516592,0.001534401,0.003388777,0.0003979628,0.004526942,0.00005262579],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946004,0.001966293,0.0001748595,0.0003648861,0.0001666012,0.0006119988,0.00063352,0.00003394371,0.001447554],"genre_scores_gemma":[0.99453,0.0008920759,0.0002747428,0.0004883702,0.0002143911,0.0005226938,0.001129988,0.000008024013,0.001939771],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004725096,"threshold_uncertainty_score":0.01580703,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.486750033343286,"score_gpt":0.5485222390582111,"score_spread":0.06177220571492509,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}